|
 |
| CASE REPORT |
|
| Year : 2012 | Volume
: 4
| Issue : 3 | Page : 176-178 |
|
|
N-acetylcysteine in the treatment of trichotillomania
Ana Rita Rodrigues-Barata1, Antonella Tosti2, Antonio Rodríguez-Pichardo1, Francisco Camacho-Martínez1
1 Department of Dermatology and Venereology, Hospital Universitario Virgen Macarena, Seville, Spain
2 Department of Dermatology and Cutaneous Surgery, University of Miami, Miller School of Medicine, FL, USA
| Date of Web Publication | 24-Aug-2012 |
Correspondence Address:
Ana Rita Rodrigues-Barata
Department of Dermatology and Venereology, Hospital Universitario Virgen Macarena, Av Dr Fedriani s/n, Sevilha, España
Spain
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0974-7753.100090
 Abstract | | |
Trichotillomania is as medical condition caused by the patient himself by pulling out of is own hair, resulting in a perceptible hair loss pattern that frequently is associated with other psychiatric processes. Generally has a chronic course in most patients, and a challenging therapeutical management. There are several available options for is treatment, but the clinical response is not satisfactory in many patients. Recently, N-acetylcisteine, a glutamate modulator, has shown efficacy in the treatment of trichotillomania and other compulsive behaviors, and is considered a new alternative in the management of this condition. We describe two patients with trichotillomania successfully treated with N-acetylcysteine. Nevertheless, further studies need to be conducted to establish the appropriate treatment regimen and to evaluate it long-term efficacy in improving this chronic condition. Keywords: Compulsive behavior, N-acetylcysteine, treatment, trichotillomania
How to cite this article:
Rodrigues-Barata AR, Tosti A, Rodríguez-Pichardo A, Camacho-Martínez F. N-acetylcysteine in the treatment of trichotillomania. Int J Trichol 2012;4:176-8 |
| Introduction | |  |
Trichotillomania consists of the recurrent compulsive habit of pulling out of one's own hair, resulting in a perceptible hair loss pattern that frequently is associated with other psychiatric processes, and social or functional impairment. It can be a self-limiting symptom but in most cases is a chronic disorder with frequent remissions and relapses. Therapeutical management is difficult and behavioral therapy, psychotherapy, hypnosis, or pharmacological treatment has been used without satisfactory results. Recently, N-acetylcysteine has been proposed as an effective alternative in the treatment of this disorder. [1] We describe 2 patients with trichotillomania successfully treated with N-acetylcysteine.
| Case Report | | |
The first patient was a 23-year-old woman that attended at our outpatient Dermatology Department with partial alopecia of her eyebrows, eyelashes, and frontal hairline of the scalp. The disorder was related with the death of her mother during childhood. On physical examination, patchy alopecia in eyebrows, eyelashes and in the frontal area was noted, with somewhat artificial appearance and presence of hairs with different length [Figure 1]a. In the past she had received treatment with fluoxetine and psychotherapy but it was ineffective. N-acetylcysteine 1,200 mg/day was started and complete regrowth occurred in the frontal area within the first two months of treatment, which maintained until the 6-month follow-up period [Figure 1]b.  | Figure 1: (a) Patchy alopecia in frontal area with presence of hairs with different length; (b) Complete regrowth in the frontal area after two month treatment with N-acetylcysteine
Click here to view |
No response was observed in eyelashes and eyebrows. The second patient was a 19-year-old woman with an irresistible urge to pull out of her hair since the age of 9. Once the diagnosis of trichotillomania was made she tried different treatments without satisfactory response. She presented diffuse hair loss affecting the entire scalp with broken hairs and hairs with different lengths on dermatoscopic examination [Figure 2]a. Eyelashes and eyebrows were preserved. Complete regrowth was observed after introducing N-acetylcisteine 1,200 mg/day during 3 months [Figure 2]b. No adverse events with the medication were reported in both patients. | Figure 2: Dermoscopic examination before (a) and after (b) three month treatment with N-acetylcysteine 1,200 mg/day
Click here to view |
| Discussion | | |
Trichotillomania is a traumatic alopecia caused by the patient himself by pulling out of the hair with the aim of tearing it off. The incidence it's not known with exactitude, but it is estimated that affects between 0.6-1% of the population. [2] It can appear in any hair-bearing area, but the most frequent locations are the scalp and eyebrows, while the eyelashes are exceptionally affected. The alopecia presents with an artificial pattern, with circular or lineal forms, and fractured hairs at different lengths. [3] The disorder can be associated with trichofagia, onichofagia and other self-inflicted cutaneous mutilations, as well as trichobezoar.
Trichotillomania management is often challenging. It depends on the beginning-age of the disorder and of the possible associated co-morbidities. In any case is important to establish a good doctor-patient relationship, to inform and advice about the nature of the disorder and recommend a psychiatric evaluation. Between the available pharmacological treatments for trichotillomania, tricyclic antidepressant clomipramine has shown to be effective, but often the patient adherence is poor and the results are modest. Also, selective serotoninergic receptor reuptake inhibitors (SSRIs) have been considered as a first line treatment for this disorder but there is no evidence that supports its benefits. [4] Furthermore, some agents, such as naltrexone or neuroleptics, like pimozide, have been used in combination with other alternatives. [5],[6] Habit reversal training is the most effective behavioral therapy, and should be associated with pharmacological treatment.
Recently several reports have indicated that N-acetylcysteine, a glutamate modulator, could be effective in reducing symptoms of trichotillomania. It acts by restoring the extracellular glutamate concentration in the nucleus accumbens, decreasing its levels, which seem responsible for the pathogenesis of compulsive behaviors, and therefore, trichotillomania. [7]
Grant et al. conducted an aleatorized double-blind clinical trial, comparing N-acetylcysteine with placebo, with doses ranging between 1200 and 2400 mg per day and have observed that it was more effective and safe than placebo, and that also produced better results than other pharmacological alternatives, with no reported adverse events. [1]
Nevertheless, the promising results N-acetylcysteine is showing further studies need to be conducted to establish the appropriate treatment regimen and to evaluate it long-term efficacy in improving this chronic condition.
| References | | |
| 1. | Grant JE, Odlaug BL, Kim SW. N-acetylcysteine, a glutamate modulator in the treatment of trichotillomania. Arch Gen Psychiatry 2009;66:756-63 
|
| 2. | Papazisis G, Tzellos T, Kouvelas D. Practice corner: managing trichotillomania - no need to pull your hair out. Evid Based Med. 2008;13:66- 7
|
| 3. | Hautmann G, Hercogova J, Lotti T. Trichotillomania. J Am Acad Dermatol. 2002;46:807-21
|
| 4. | Bloch MH, Landeros-Weisenberger A, Dombrowski P, Kelmendi B, Wegner R, Nudel J, et al. Systematic review: Pharmacological and behavioral treatment for trichotillomania. Biol Psychiatry 2007;62:839-46.
[PUBMED] |
| 5. | Stein DJ, Hollander E. Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of trichotillomania. J Clin Psychiatry 1992;53:123-6.
[PUBMED] |
| 6. | De Sousa A. An open-label pilot study of naltrexone in childhood-onset trichotillomania. J Child Adolesc Psychopharmacol 2008;18:30-3.
[PUBMED] |
| 7. | Odlaug BL, Grant JE. N-acetyl cysteine in the treatment of grooming disorders. J Clin Psychopharmacol 2007;27:227-9.
[PUBMED] |
[Figure 1], [Figure 2]
| This article has been cited by | | 1 |
The Potential of N-Acet³yl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders |
|
| Richard C. J. Bradlow, Michael Berk, Peter W. Kalivas, Sudie E. Back, Richard A. Kanaan | | CNS Drugs. 2022; | | [Pubmed] | [DOI] | | | 2 |
The Potential of N-Acetylcysteine for Treatment of Trichotillomania, Excoriation Disorder, Onychophagia, and Onychotillomania: An Updated Literature Review |
|
| Debra K. Lee, Shari R. Lipner | | International Journal of Environmental Research and Public Health. 2022; 19(11): 6370 | | [Pubmed] | [DOI] | | | 3 |
“N-Acetylcysteine for Obsessive-Compulsive and Related Disorders in Children and Adolescents: A Review” |
|
| Gabrielle M. Parli, Mark A. Gales, Barry J. Gales | | Annals of Pharmacotherapy. 2022; : 1060028022 | | [Pubmed] | [DOI] | | | 4 |
Dramatic Improvement of Trichotillomania with 6 Months of Treatment With N-Acetylcysteine |
|
| Lilia Popova, Jennifer Mancuso | | Global Pediatric Health. 2022; 9: 2333794X22 | | [Pubmed] | [DOI] | | | 5 |
N
-acetylcysteine as a new prominent approach for treating psychiatric disorders
|
|
| Irena Smaga, Malgorzata Frankowska, Malgorzata Filip | | British Journal of Pharmacology. 2021; 178(13): 2569 | | [Pubmed] | [DOI] | | | 6 |
Hair-pulling
disorder (Trichotillomania): Etiopathogenesis, diagnosis and treatment in a nutshell
|
|
| Julio Torales, Noelia Ruiz Díaz, Antonio Ventriglio, João Mauricio Castaldelli-Maia, Iván Barrios, Oscar García, Rodrigo Navarro, Israel González-Urbieta, Marcelo O'Higgins, Mohammad Jafferany | | Dermatologic Therapy. 2021; 34(1) | | [Pubmed] | [DOI] | | | 7 |
Pharmacotherapy for trichotillomania |
|
| Jacob Hoffman, Taryn Williams, Rachel Rothbart, Jonathan C Ipser, Naomi Fineberg, Samuel R Chamberlain, Dan J Stein | | Cochrane Database of Systematic Reviews. 2021; 2021(9) | | [Pubmed] | [DOI] | | | 8 |
Sensory symptoms in body-focused repetitive behaviors, restless legs syndrome, and Tourette syndrome: An overlap? |
|
| James Badenoch, Tamara Searle, Iona Watson, Andrea E. Cavanna | | Neuroscience & Biobehavioral Reviews. 2020; 119: 320 | | [Pubmed] | [DOI] | | | 9 |
Psychopharmacology in dermatology: Treatment of primary psychiatric conditions in dermatology |
|
| Julio Torales, Osvaldo Melgarejo, Israel González, Oscar García, Iván Barrios, Mohammad Jafferany | | Dermatologic Therapy. 2020; 33(4) | | [Pubmed] | [DOI] | | | 10 |
Trichoteiromania in adults |
|
| Anastasia N. Mareeva, Irina M. Pichugina | | Vestnik dermatologii i venerologii. 2020; 96(2): 44 | | [Pubmed] | [DOI] | | | 11 |
Trichoteiromania: Good Response to Treatment with N-Acetylcysteine |
|
| Corina Isabel Salas-Callo, Rodrigo Pirmez | | Skin Appendage Disorders. 2019; 5(4): 242 | | [Pubmed] | [DOI] | | | 12 |
Obsessive-Compulsive Disorder in Children and Adolescents |
|
| Valerie Tobin | | Journal of Psychosocial Nursing and Mental Health Services. 2018; 56(3): 15 | | [Pubmed] | [DOI] | | | 13 |
N-acetylcysteine in dermatology |
|
| Mohammad Adil, SyedSuhail Amin, Mohd Mohtashim | | Indian Journal of Dermatology, Venereology and Leprology. 2018; 84(6): 652 | | [Pubmed] | [DOI] | | | 14 |
Lower Posterior Cingulate Cortex Glutathione Levels in Obsessive-Compulsive Disorder |
|
| Brian P. Brennan, J. Eric Jensen, Christine Perriello, Harrison G. Pope Jr., Michael A. Jenike, James I. Hudson, Scott L. Rauch, Marc J. Kaufman | | Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. 2016; 1(2): 116 | | [Pubmed] | [DOI] | | | 15 |
N-acetylcysteine in trichotillomania: further thoughts |
|
| J.M.R. Goulding | | British Journal of Dermatology. 2015; : n/a | | [Pubmed] | [DOI] | | | 16 |
N-Acetyl Cysteine in the Treatment of Obsessive Compulsive and Related Disorders: A Systematic Review |
|
| Georgina Oliver,Olivia Dean,David Camfield,Scott Blair-West,Chee Ng,Michael Berk,Jerome Sarris | | Clinical Psychopharmacology and Neuroscience. 2015; 13(1): 12 | | [Pubmed] | [DOI] | | | 17 |
Diagnosis and Management of Alopecia in Children |
|
| Leslie Castelo-Soccio | | Pediatric Clinics of North America. 2014; 61(2): 427 | | [Pubmed] | [DOI] | | | 18 |
Alopecias |
|
| I. Bernad Alonso,J.M. Lera Imbuluzqueta,I. Irarrazaval Armendáriz,A. España Alonso | | Medicine - Programa de Formación Médica Continuada Acreditado. 2014; 11(48): 2840 | | [Pubmed] | [DOI] | | | 19 |
Glutamatergic Dysfunction in Skin-Picking Disorder |
|
| Ipek Percinel,Kemal Utku Yazici | | Journal of Clinical Psychopharmacology. 2014; 34(6): 772 | | [Pubmed] | [DOI] | | | 20 |
N-acetylcysteine in trichotillomania: a panacea for compulsive skin disorders? |
|
| M. Taylor,K. Bhagwandas | | British Journal of Dermatology. 2014; : n/a | | [Pubmed] | [DOI] | | | 21 |
An open-label pilot study ofN-acetylcysteine for skin-picking in Prader-Willi syndrome |
|
| Jennifer L. Miller,Moris Angulo | | American Journal of Medical Genetics Part A. 2014; 164(2): 421 | | [Pubmed] | [DOI] | | | 22 |
Drug-induced impulse control disorders: A review |
|
| Atmaca, M. | | Current Clinical Pharmacology. 2014; 9(1): 70-74 | | [Pubmed] | | | 23 |
An open-label pilot study of N-acetylcysteine for skin-picking in Prader-Willi syndrome |
|
| Miller, J.L., Angulo, M. | | American Journal of Medical Genetics, Part A. 2014; 164(2): 421-424 | | [Pubmed] | | | 24 |
Obsessive-compulsive disorder in dermatology | [Trastorno obsesivo-compulsivo en dermatología] |
|
| Rodríguez-Pichardo, A. | | Piel. 2013; 28(8): 469-479 | | [Pubmed] | | | 25 |
Value of trichoscopy versus trichogram for diagnosis of female androgenetic alopecia |
|
| Galliker, N.A., Trüeb, R.M. | | Source of the Document International Journal of Trichology. 2012; 4(1): 19-22 | | [Pubmed] | |
|
 |
|
|
|
